Biologics X 3DCC Conference 2026: Merging Innovation, Drug Development, and Translation for the Next Era of Biopharma
Registrations OPEN India's first of-its-kind, 6th Annual Summit on Biopharmaceutical Product Development in conjunction…
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy
First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
Vantive partners with IDBS to drive global digital transformation in vital organ therapy
WOKING, United Kingdom, Dec. 2, 2025 /PRNewswire/ -- IDBS, a Danaher company…
Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP Technology at 2025 World ADC Awards
Recognition underscores Ajinomoto Bio-Pharma Services' innovation and scientific excellence in advancing next-generation…
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered,…
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 10, 2025 21:56 ET | Source: Vor Biopharma BOSTON, Nov. 10,…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
Virtuosi 2.0 – Unleashed
The Next Generation of BioPharma Education for the Advanced Manufacturing Era ALEXANDRIA,…
CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
MELBOURNE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ("Propanc"…